ANNEXON
ANNX Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-02-27
2025-03-03
LEW JENNIFER
EVP & CHIEF FINANCIAL OFFICER
A - Grant
Stock Option (Right to Buy)
273K
$0.00
1
$283.06M
2025-02-27
2025-03-03
LOVE DOUGLAS
PRESIDENT AND CEO
A - Grant
Stock Option (Right to Buy)
1.30M
$0.00
1
$283.06M
2025-02-27
2025-03-03
YEDNOCK TED
EVP & CHIEF INNOVATION OFFICER
A - Grant
Stock Option (Right to Buy)
273K
$0.00
1
$283.06M
2025-02-27
2025-03-03
ARTIS DEAN RICHARD
EVP & CHIEF SCIENTIFIC OFFICER
A - Grant
Stock Option (Right to Buy)
273K
$0.00
1
$283.06M
2025-02-27
2025-03-03
OVERDORF MICHAEL
EVP & CHIEF BUSINESS OFFICER
A - Grant
Stock Option (Right to Buy)
273K
$0.00
1
$283.06M
2025-02-27
2025-03-03
DANANBERG JAMIE
CHIEF MEDICAL OFFICER
A - Grant
Stock Option (Right to Buy)
228K
$0.00
1
$283.06M
2024-02-27
2025-03-03
LEW JENNIFER
EVP & CHIEF FINANCIAL OFFICER
A - Grant
Common Stock
44,963
$0.00
1
$283.06M
2024-02-27
2025-03-03
ARTIS DEAN RICHARD
EVP & CHIEF SCIENTIFIC OFFICER
A - Grant
Common Stock
44,963
$0.00
1
$283.06M
2024-02-27
2025-03-03
DANANBERG JAMIE
CHIEF MEDICAL OFFICER
A - Grant
Common Stock
44,963
$0.00
1
$283.06M
2024-02-27
2025-03-03
OVERDORF MICHAEL
EVP & CHIEF BUSINESS OFFICER
A - Grant
Common Stock
44,963
$0.00
1
$283.06M
2024-02-27
2025-03-03
YEDNOCK TED
EVP & CHIEF INNOVATION OFFICER
A - Grant
Common Stock
44,963
$0.00
1
$283.06M
2025-02-18
2025-02-20
ARTIS DEAN RICHARD
EVP & CHIEF SCIENTIFIC OFFICER
S - Sale
Common Stock
-5,515
$3.00
-16,545
1
$283.06M
2025-02-18
2025-02-20
DANANBERG JAMIE
CHIEF MEDICAL OFFICER
S - Sale
Common Stock
-5,521
$3.00
-16,563
1
$283.06M
2025-02-18
2025-02-20
LEW JENNIFER
EVP & CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-6,912
$3.00
-20,736
1
$283.06M
2025-02-18
2025-02-20
OVERDORF MICHAEL
EVP & CHIEF BUSINESS OFFICER
S - Sale
Common Stock
-6,618
$3.00
-19,854
1
$283.06M
2025-02-18
2025-02-20
YEDNOCK TED
EVP & CHIEF INNOVATION OFFICER
S - Sale
Common Stock
-8,345
$3.00
-25,035
1
$283.06M
2025-02-18
2025-02-18
LEW JENNIFER
EVP & CHIEF FINANCIAL OFFICER
S - Sale
-8,338
$3.00
-25,014
1
$283.06M
2025-02-13
2025-02-18
LEW JENNIFER
EVP & CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-1,786
$3.00
-5,358
1
$283.06M
2025-02-13
2025-02-18
LOVE DOUGLAS
PRESIDENT AND CEO
S - Sale
Common Stock
-5,021
$3.00
-15,063
1
$283.06M
2025-02-13
2025-02-18
OVERDORF MICHAEL
EVP & CHIEF BUSINESS OFFICER
S - Sale
Common Stock
-1,425
$3.00
-4,275
1
$283.06M
2025-02-13
2025-02-18
YEDNOCK TED
EVP & CHIEF INNOVATION OFFICER
S - Sale
Common Stock
-1,783
$3.00
-5,349
1
$283.06M
2025-01-06
2025-01-08
LOVE DOUGLAS
PRESIDENT AND CEO
M - Exercise
Stock Option (Right to Buy)
-37,994
$0.00
1
$283.06M
2025-01-06
2025-01-08
LOVE DOUGLAS
PRESIDENT AND CEO
M - Exercise
Common Stock
37,994
$1.00
37,994
1
$283.06M
2024-10-30
2024-11-01
LOVE DOUGLAS
PRESIDENT AND CEO
M - Exercise
Stock Option (Right to Buy)
-114K
$0.00
2
$283.06M
2024-10-15
2024-10-17
YEDNOCK TED
EVP & CHIEF INNOVATION OFFICER
S - Sale
Common Stock
-5,408
$7.00
-37,856
1
$283.06M
2024-10-15
2024-10-17
YEDNOCK TED
EVP & CHIEF INNOVATION OFFICER
M - Exercise
Stock Option (Right to Buy)
-5,408
$0.00
1
$283.06M
2024-10-15
2024-10-17
YEDNOCK TED
EVP & CHIEF INNOVATION OFFICER
M - Exercise
Common Stock
5,408
$2.00
10,816
1
$283.06M
2024-09-19
2024-09-20
YEDNOCK TED
EVP & CHIEF INNOVATION OFFICER
S - Sale
Common Stock
-4,500
$7.00
-31,500
1
$283.06M
2024-09-12
2024-09-16
YEDNOCK TED
EVP & CHIEF INNOVATION OFFICER
S - Sale
Common Stock
-5,500
$6.00
-33,000
1
$283.06M
2024-09-05
2024-09-06
YEDNOCK TED
EVP & CHIEF INNOVATION OFFICER
S - Sale
Common Stock
-5,500
$6.00
-33,000
1
$283.06M
2024-08-29
2024-08-30
YEDNOCK TED
EVP & CHIEF INNOVATION OFFICER
S - Sale
Common Stock
-5,500
$6.00
-33,000
1
$283.06M
2024-07-15
2024-07-17
YEDNOCK TED
EVP & CHIEF INNOVATION OFFICER
S - Sale
Common Stock
-1,106
$6.00
-6,636
1
$283.06M
2024-07-15
2024-07-17
LEW JENNIFER
EVP & CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-1,104
$6.00
-6,624
1
$283.06M
2024-07-15
2024-07-17
OVERDORF MICHAEL
EVP & CHIEF BUSINESS OFFICER
S - Sale
Common Stock
-784
$6.00
-4,704
1
$283.06M
2024-02-20
2024-02-21
LEW JENNIFER
EVP & CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-2,593
$6.00
-15,558
1
$283.06M
2024-02-20
2024-02-21
OVERDORF MICHAEL
EVP & CHIEF BUSINESS OFFICER
S - Sale
Common Stock
-1,951
$5.00
-9,755
1
$283.06M
2024-02-20
2024-02-21
YEDNOCK TED
EVP & CHIEF INNOVATION OFFICER
S - Sale
Common Stock
-2,604
$6.00
-15,624
1
$283.06M
2024-02-16
2024-02-21
DANANBERG JAMIE
CHIEF MEDICAL OFFICER
A - Grant
Stock Option (Right to Buy)
160K
$0.00
1
$283.06M
2024-02-16
2024-02-21
DANANBERG JAMIE
CHIEF MEDICAL OFFICER
A - Grant
Common Stock
39,000
$0.00
1
$283.06M
2024-02-16
2024-02-21
LEW JENNIFER
EVP & CHIEF FINANCIAL OFFICER
A - Grant
Stock Option (Right to Buy)
160K
$0.00
1
$283.06M
2024-02-16
2024-02-21
LEW JENNIFER
EVP & CHIEF FINANCIAL OFFICER
A - Grant
Common Stock
39,000
$0.00
1
$283.06M
2024-02-16
2024-02-21
LOVE DOUGLAS
PRESIDENT AND CEO
A - Grant
Stock Option (Right to Buy)
656K
$0.00
1
$283.06M
2024-02-16
2024-02-21
OVERDORF MICHAEL
EVP & CHIEF BUSINESS OFFICER
A - Grant
Stock Option (Right to Buy)
160K
$0.00
1
$283.06M
2024-02-16
2024-02-21
OVERDORF MICHAEL
EVP & CHIEF BUSINESS OFFICER
A - Grant
Common Stock
39,000
$0.00
1
$283.06M
2024-02-16
2024-02-21
YEDNOCK TED
EVP & CHIEF INNOVATION OFFICER
A - Grant
Stock Option (Right to Buy)
160K
$0.00
1
$283.06M
2024-02-16
2024-02-21
YEDNOCK TED
EVP & CHIEF INNOVATION OFFICER
A - Grant
Common Stock
39,000
$0.00
1
$283.06M
2024-02-16
2024-02-21
ARTIS DEAN RICHARD
EVP & CHIEF SCIENTIFIC OFFICER
A - Grant
Stock Option (Right to Buy)
160K
$0.00
1
$283.06M
2024-02-16
2024-02-21
ARTIS DEAN RICHARD
EVP & CHIEF SCIENTIFIC OFFICER
A - Grant
Common Stock
39,000
$0.00
1
$283.06M
2024-02-12
2024-02-14
LOVE DOUGLAS
PRESIDENT AND CEO
S - Sale
Common Stock
-5,782
$6.00
-34,692
1
$283.06M
2024-02-12
2024-02-14
LEW JENNIFER
EVP & CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-1,809
$6.00
-10,854
1
$283.06M
2024-02-12
2024-02-14
OVERDORF MICHAEL
EVP & CHIEF BUSINESS OFFICER
S - Sale
Common Stock
-1,349
$6.00
-8,094
1
$283.06M
2024-02-12
2024-02-14
YEDNOCK TED
EVP & CHIEF INNOVATION OFFICER
S - Sale
Common Stock
-1,810
$6.00
-10,860
1
$283.06M
2023-12-27
2024-01-23
YEDNOCK TED
EVP & Chief Innovation Officer
M - Exercise
Common Stock
21,000
$2.00
42,000
2
$283.06M
2023-12-27
2024-01-23
YEDNOCK TED
EVP & Chief Innovation Officer
S - Sale
Common Stock
-21,000
$5.00
-105K
1
$283.06M
2023-07-11
2024-01-23
LEW JENNIFER
EVP & Chief Financial Officer
S - Sale
Common Stock
-1,057
$4.00
-4,228
1
$283.06M
2023-07-11
2024-01-23
OVERDORF MICHAEL
EVP & Chief Business Officer
S - Sale
Common Stock
-978
$4.00
-3,912
1
$283.06M
2023-07-11
2024-01-23
YEDNOCK TED
EVP & Chief Innovation Officer
S - Sale
Common Stock
-1,057
$4.00
-4,228
1
$283.06M
2023-12-27
2023-12-29
YEDNOCK TED
EVP & Chief Innovation Officer
S - Sale
Common Stock
-21,000
$5.00
-105K
1
$283.06M
2023-12-27
2023-12-29
YEDNOCK TED
EVP & Chief Innovation Officer
M - Exercise
Stock Option (Right to Buy)
-21,000
$0.00
2
$283.06M
2023-12-27
2023-12-29
YEDNOCK TED
EVP & Chief Innovation Officer
M - Exercise
Common Stock
21,000
$2.00
42,000
2
$283.06M
2023-08-01
2023-08-02
DANANBERG JAMIE
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
275K
$0.00
1
$283.06M
2023-07-13
2023-07-13
OVERDORF MICHAEL
EVP & CHIEF BUSINESS OFFICER
S - Sale
-978
$4.00
-3,912
1
$283.06M
2023-05-25
2023-05-30
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC
P - Purchase
Common Stock
300K
$2.00
600K
1
$283.06M
2023-02-16
2023-02-21
LEW JENNIFER
EVP & Chief Financial Officer
A - Grant
Common Stock
18,975
$0.00
1
$283.06M
2023-02-16
2023-02-21
LEW JENNIFER
EVP & Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
77,050
$0.00
1
$283.06M
2023-02-16
2023-02-21
LOVE DOUGLAS
President & CEO
A - Grant
Stock Option (Right to Buy)
345K
$0.00
1
$283.06M
2023-02-16
2023-02-21
OVERDORF MICHAEL
EVP & Chief Business Officer
A - Grant
Stock Option (Right to Buy)
77,050
$0.00
1
$283.06M
2023-02-16
2023-02-21
OVERDORF MICHAEL
EVP & Chief Business Officer
A - Grant
Common Stock
18,975
$0.00
1
$283.06M
2023-02-14
2023-02-15
LEW JENNIFER
EVP & Chief Financial Officer
S - Sale
Common Stock
-166
$6.00
-996
1
$283.06M
2023-02-14
2023-02-15
OVERDORF MICHAEL
EVP & Chief Business Officer
S - Sale
Common Stock
-144
$6.00
-864
1
$283.06M
2023-02-13
2023-02-15
LEW JENNIFER
EVP & Chief Financial Officer
S - Sale
Common Stock
-1,742
$6.00
-10,452
1
$283.06M
2023-02-13
2023-02-15
OVERDORF MICHAEL
EVP & Chief Business Officer
S - Sale
Common Stock
-1,501
$6.00
-9,006
1
$283.06M
2023-01-15
2023-01-18
ARTIS DEAN RICHARD
EVP & Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
210K
$0.00
1
$283.06M
2022-07-11
2022-07-13
LOVE DOUGLAS
President & CEO
A - Grant
Stock Option (Right to Buy)
300K
$0.00
1
$283.06M
2022-07-11
2022-07-13
MATTHEAKIS LARRY
EVP & Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
37,500
$0.00
1
$283.06M
2022-07-11
2022-07-13
LEW JENNIFER
EVP & Chief Financial Officer
A - Grant
Common Stock
9,375
$0.00
1
$283.06M
2022-07-11
2022-07-13
MATTHEAKIS LARRY
EVP & Chief Scientific Officer
A - Grant
Common Stock
4,688
$0.00
1
$283.06M
2022-07-11
2022-07-13
LEW JENNIFER
EVP & Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
75,000
$0.00
1
$283.06M
2022-07-11
2022-07-13
OVERDORF MICHAEL
EVP & Chief Business Officer
A - Grant
Stock Option (Right to Buy)
75,000
$0.00
1
$283.06M
2022-07-11
2022-07-13
OVERDORF MICHAEL
EVP & Chief Business Officer
A - Grant
Common Stock
9,375
$0.00
1
$283.06M
2022-02-11
2022-02-15
LEW JENNIFER
EVP & Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
100K
$0.00
1
$283.06M
2022-02-11
2022-02-15
KESWANI SANJAY
EVP & Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
100K
$0.00
1
$283.06M
2022-02-11
2022-02-15
KESWANI SANJAY
EVP & Chief Medical Officer
A - Grant
Common Stock
12,500
$0.00
1
$283.06M
2022-02-11
2022-02-15
LEW JENNIFER
EVP & Chief Financial Officer
A - Grant
Common Stock
12,500
$0.00
1
$283.06M
2022-02-11
2022-02-15
LOVE DOUGLAS
President & CEO
A - Grant
Stock Option (Right to Buy)
320K
$0.00
1
$283.06M
2022-02-11
2022-02-15
MATTHEAKIS LARRY
EVP & Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
100K
$0.00
1
$283.06M
2022-02-11
2022-02-15
MATTHEAKIS LARRY
EVP & Chief Scientific Officer
A - Grant
Common Stock
12,500
$0.00
1
$283.06M
2022-02-11
2022-02-15
OVERDORF MICHAEL
EVP & Chief Business Officer
A - Grant
Stock Option (Right to Buy)
100K
$0.00
1
$283.06M
2022-02-11
2022-02-15
OVERDORF MICHAEL
EVP & Chief Business Officer
A - Grant
Common Stock
12,500
$0.00
1
$283.06M
2021-11-11
2021-11-15
LOVE DOUGLAS
President & CEO
M - Exercise
Stock Option (Right to Buy)
-101K
$0.00
2
$283.06M
2021-09-30
2021-10-04
MATTHEAKIS LARRY
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
220K
$0.00
1
$283.06M
2021-09-16
2021-09-20
LOVE DOUGLAS
President & CEO
M - Exercise
Stock Option (Right to Buy)
-7,500
$0.00
1
$283.06M
2021-09-13
2021-09-15
YEDNOCK TED
EVP & Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-16,190
$0.00
2
$283.06M
2021-09-13
2021-09-15
LEW JENNIFER
EVP & Chief Financial Officer
S - Sale
Common Stock
-3,500
$20.00
-70,000
1
$283.06M
2021-09-13
2021-09-15
YEDNOCK TED
EVP & Chief Scientific Officer
S - Sale
Common Stock
-16,190
$20.00
-324K
1
$283.06M
2021-09-13
2021-09-15
LEW JENNIFER
EVP & Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-3,500
$0.00
1
$283.06M
2021-09-13
2021-09-15
LEW JENNIFER
EVP & Chief Financial Officer
M - Exercise
Common Stock
3,500
$7.00
24,500
1
$283.06M
2021-09-13
2021-09-15
YEDNOCK TED
EVP & Chief Scientific Officer
M - Exercise
Common Stock
16,190
$2.00
32,380
2
$283.06M
2021-06-08
2021-06-09
LOVE DOUGLAS
President & CEO
M - Exercise
Stock Option (Right to Buy)
-3,750
$0.00
1
$283.06M
2021-06-07
2021-06-09
LOVE DOUGLAS
President & CEO
M - Exercise
Stock Option (Right to Buy)
-3,750
$0.00
1
$283.06M
2021-06-03
2021-06-07
YEDNOCK TED
EVP & Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-15,000
$0.00
1
$283.06M
2021-06-03
2021-06-07
YEDNOCK TED
EVP & Chief Scientific Officer
M - Exercise
Common Stock
15,000
$1.00
15,000
1
$283.06M
2021-06-03
2021-06-07
YEDNOCK TED
EVP & Chief Scientific Officer
S - Sale
Common Stock
-15,000
$21.00
-315K
2
$283.06M
2021-05-27
2021-06-01
LEW JENNIFER
EVP & Chief Financial Officer
S - Sale
Common Stock
-3,500
$22.00
-77,000
1
$283.06M
2021-05-27
2021-06-01
LEW JENNIFER
EVP & Chief Financial Officer
M - Exercise
Common Stock
3,500
$7.00
24,500
1
$283.06M
2021-05-27
2021-06-01
LEW JENNIFER
EVP & Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-3,500
$0.00
1
$283.06M
2021-04-01
2021-04-02
LOVE DOUGLAS
President & CEO
M - Exercise
Stock Option (Right to Buy)
-500
$0.00
1
$283.06M
2021-03-31
2021-04-02
LOVE DOUGLAS
President & CEO
M - Exercise
Stock Option (Right to Buy)
-7,102
$0.00
1
$283.06M
2021-03-30
2021-03-31
LOVE DOUGLAS
President & CEO
M - Exercise
Stock Option (Right to Buy)
-3,750
$0.00
1
$283.06M
2021-03-29
2021-03-31
LOVE DOUGLAS
President & CEO
M - Exercise
Stock Option (Right to Buy)
-3,750
$0.00
1
$283.06M
2021-03-25
2021-03-29
YEDNOCK TED
EVP & Chief Scientific Officer
S - Sale
Common Stock
-16,175
$29.00
-469K
3
$283.06M
2021-03-25
2021-03-29
YEDNOCK TED
EVP & Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-16,175
$0.00
2
$283.06M
2021-03-25
2021-03-29
YEDNOCK TED
EVP & Chief Scientific Officer
M - Exercise
Common Stock
16,175
$2.00
32,350
2
$283.06M
2021-03-24
2021-03-26
KESWANI SANJAY
EVP & Chief Medical Officer
S - Sale
Common Stock
-3,995
$30.00
-120K
1
$283.06M
2021-03-24
2021-03-26
KESWANI SANJAY
EVP & Chief Medical Officer
M - Exercise
Stock Option (Right to Buy)
-3,995
$0.00
1
$283.06M
2021-03-24
2021-03-26
KESWANI SANJAY
EVP & Chief Medical Officer
M - Exercise
Common Stock
3,995
$7.00
27,965
1
$283.06M
2021-03-23
2021-03-25
LEW JENNIFER
EVP & Chief Financial Officer
S - Sale
Common Stock
-5,000
$28.00
-140K
3
$283.06M
2021-03-23
2021-03-25
LEW JENNIFER
EVP & Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-5,000
$0.00
1
$283.06M
2021-03-23
2021-03-25
LEW JENNIFER
EVP & Chief Financial Officer
M - Exercise
Common Stock
5,000
$7.00
35,000
1
$283.06M
2021-02-25
2021-03-01
LOVE DOUGLAS
President & CEO
A - Grant
Stock Option (Right to Buy)
325K
$0.00
1
$283.06M
2021-02-25
2021-03-01
KESWANI SANJAY
EVP & Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
115K
$0.00
1
$283.06M
2021-02-25
2021-03-01
LEW JENNIFER
EVP & Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
115K
$0.00
1
$283.06M
2021-02-25
2021-03-01
OVERDORF MICHAEL
EVP & Chief Business Officer
A - Grant
Stock Option (Right to Buy)
115K
$0.00
1
$283.06M
2021-02-25
2021-03-01
YEDNOCK TED
EVP & Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
115K
$0.00
1
$283.06M
2020-07-28
2020-07-30
CLARUS LIFESCIENCES III, L.P.
C - Conversion
Series A-1 Redeemable Convertible Preferred Stock
-5.67M
1
$283.06M
2020-07-28
2020-07-30
CLARUS LIFESCIENCES III, L.P.
C - Conversion
Series B Redeemable Convertible Preferred Stock
-8.37M
1
$283.06M
2020-07-28
2020-07-30
CLARUS LIFESCIENCES III, L.P.
C - Conversion
Series C Redeemable Convertible Preferred Stock
-6.15M
1
$283.06M
2020-07-28
2020-07-30
CLARUS LIFESCIENCES III, L.P.
C - Conversion
Series D Redeemable Convertible Preferred Stock
-2.11M
1
$283.06M
2020-07-28
2020-07-30
CLARUS LIFESCIENCES III, L.P.
P - Purchase
Common Stock
200K
$17.00
3.40M
1
$283.06M
2020-07-28
2020-07-30
REDMILE GROUP, LLC
C - Conversion
Series D Redeemable Convertible Preferred Stock
-14M
$0.00
1
$283.06M
2020-07-28
2020-07-28
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC
P - Purchase
Common Stock
400K
$17.00
6.80M
1
$283.06M
2020-07-28
2020-07-28
LEW JENNIFER
EVP & Chief Financial Officer
P - Purchase
Common Stock
2,000
$17.00
34,000
1
$283.06M
2020-07-28
2020-07-28
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC
C - Conversion
Series C Preferred Stock
-22M
1
$283.06M
2020-07-28
2020-07-28
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC
C - Conversion
Series D Preferred Stock
-2.81M
1
$283.06M
2020-07-28
2020-07-28
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC
C - Conversion
Common Stock
2.84M
2
$283.06M
2020-07-23
2020-07-24
OVERDORF MICHAEL
EVP & Chief Business Officer
A - Grant
Stock Option (Right to Buy)
243K
$0.00
1
$283.06M